The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index; 21 of the 45 sources its claims cite were checked for support.
A Digital Mental Health Support Program for Depression and Anxiety in Populations With Attention-Deficit/Hyperactivity Disorder: Feasibility and Usability Study
Open accessPublished version of a preprint
Abstract
Background: A total of 1 in 2 adults with attention-deficit/hyperactivity disorder (ADHD) struggles with major depressive or anxiety disorders. The co-occurrence of these disorders adds to the complexity of finding utility in as well as adherence to a treatment option. Digital therapeutic solutions may present a promising alternative treatment option that could mitigate these challenges and alleviate symptoms. Objective: This study aims to investigate (1) the feasibility and acceptance of a digital mental health intervention, (2) participants’ engagement and retention levels, and (3) the potential efficacy with respect to anxiety and depression symptoms in a population with ADHD. Our main hypothesis was that a digital, data-driven, and personalized intervention for adults with coexisting ADHD and depressive or anxiety symptoms would show high engagement and adherence, which would be accompanied by a decrease in depressive and anxiety symptoms along with an increase in quality of life and life satisfaction levels. Methods: This real-world data, single-arm study included 30 adult participants with ADHD symptomatology and coexisting depressive or anxiety symptoms who joined a 16-week digital, data-driven mental health support program. This intervention is based on a combination of evidence-based approaches such as cognitive behavioral therapy, mindfulness, and positive psychology techniques. The targeted symptomatology was evaluated using the Patient Health Questionnaire–9, Generalized Anxiety Disorder–7, and Barkley Adult ADHD Rating Scale–IV. Quality of life aspects were evaluated using the Satisfaction With Life Scale and the Life Satisfaction Questionnaire, and user feedback surveys were used to assess user experience and acceptability. Results: The study retention rate was 97% (29/30), and high engagement levels were observed, as depicted by the 69 minutes spent on the app per week, 5 emotion logs per week, and 11.5 mental health actions per week. An average decrease of 46.2% (P<.001; r=0.89) in depressive symptoms and 46.4% (P<.001; r=0.86) in anxiety symptoms was observed, with clinically significant improvement for more than half (17/30, 57% and 18/30, 60%, respectively) of the participants. This was followed by an average increase of 23% (P<.001; r=0.78) and 20% (P=.003; r=0.8) in Satisfaction With Life Scale and Life Satisfaction Questionnaire scores, respectively. The overall participant satisfaction level was 4.3 out of 5. Conclusions: The findings support the feasibility, acceptability, and value of the examined digital program for adults with ADHD symptomatology to address the coexisting depressive or anxiety symptoms. However, controlled trials with larger sample sizes and more diverse participant profiles are required to provide further evidence of clinical efficacy. ©Charalampos Tsirmpas, Maria Nikolakopoulou, Sharon Kaplow, Dimitrios Andrikopoulos, Panagiotis Fatouros, Konstantinos Kontoangelos, Charalabos Papageorgiou.
Overview
CoChat Summary
TL;DR
This single-arm feasibility study tested a 16-week digital mental health program for 30 adults with ADHD symptomatology and coexisting depressive or anxiety symptoms. The program showed high retention and engagement, along with large pre-post improvements in depression, anxiety, and life satisfaction, but the authors stress that controlled trials are needed.
Key findings
- Of the 30 participants, 29 (97%) completed the 16-week program; 1 (3%) discontinued for personal reasons.
- Engagement was high: participants were active 3.2 (SD 0.99) days/week, spent 69 (SD 18.04) minutes/week on the app, accessed it about 20 (SD 6.72) times/week, logged about 5 (SD 0.85) emotional events/week, and completed 3.48 (SD 0.79) mental health exercises/week.
- Depressive symptoms decreased by 46.2% from baseline to end of program (PHQ-9: 14.3 to 7.7; P<.001; r=0.89), and anxiety symptoms decreased by 46.3% (GAD-7: 11.4 to 6.1; P<.001; r=0.86).
- Clinically significant improvement was reported for 57% (17/30) for depressive symptoms and 60% (18/30) for anxiety symptoms; satisfaction was 4.3/5 overall, and life satisfaction improved (SWLS +23%, P<.001; LISAT-11 +20%, P=.004).
Methods
- Prospective, decentralized, single-arm feasibility/proof-of-concept study conducted over 16 weeks in real-world settings; recruitment ran from August 2022 to January 2023.
- Sample: 30 adults with self-reported ADHD symptomatology and coexisting depressive or anxiety symptoms; 29/30 completed the study. Eligibility required PHQ-9 ≥5 or GAD-7 ≥5, age ≥18 years, and smartphone ownership.
- Main analysis used intention-to-treat, with baseline/midprogram/end-of-program comparisons on PHQ-9, GAD-7, LISAT-11, and SWLS using Kolmogorov-Smirnov tests for normality and 2-tailed Wilcoxon signed rank tests; 4% missing survey values were imputed with multivariate feature imputation.
Limitations
- The paper states that the sample was relatively small (30 participants) and that all participants had self-reported symptoms rather than professional diagnoses, limiting generalizability.
- The lack of a control group, stated by the paper, limits the ability to attribute symptom and quality-of-life changes to the intervention.
- Evident from the text: outcomes were based on a single-arm design with a highly selected, mostly engaged sample, so placebo effects, regression to the mean, and broader real-world applicability cannot be ruled out.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
13 Valid · 2 Not valid · 7 Not checked · 90 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“adults with ADHD tend to prefer nonpharmacological options for managing their symptoms [20,21].”
§ A Digital Mental Health Support Program for Depression and Anxiety in Populations With Attention-Deficit/Hyperactivity Disorder: Feasibility and Usability Study > Introduction > Background Attention-deficit/hyperactivity disorder (ADHD), as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), is a heritable, chronic, and neurobehavioral disorder of childhood onset and is characterized by symptoms of inattentiveness and hyperactivity-impulsivity [1]. Although the exact etiology of ADHD is still unknown, there is an ever-growing body of neurobiological evidence that supports a multifaceted neurodiversity that contributes to impairment in multiple domains, such as cognitive processing, attention, motor planning, speed of processing responses, and other behavioral issues observed in ADHD [2]. Specifically, the prefrontal cortex, caudate, and cerebellum regions are interconnected by a network of neurons and together regulate attention, thoughts, emotions, behavior, and actions [1,3]. This neurobiological research adds a layer of insight into the presentation of ADHD symptoms, which begin in childhood, affecting the level of quality in social and occupational functioning, and continue to cause problems into adulthood for approximately 29% of people diagnosed [4]. The typical clinical picture of adults with ADHD is characterized by inattention or hyperfocus, hyperactivity, mind wandering, and impulsivity. Furthermore, emotional dysregulation and functional impairment are also characteristic features of adults with ADHD [1,2,5]. In terms of emotional dysregulation, the observed emotional changes are short-lived and usually triggered by daily activities [1-3,5], whereas functional deficits mainly include problems with inhibition and working memory; organizing, prioritizing, and initiating work; focusing, sustaining, and shifting attention to tasks; managing frustration; and self-regulating emotions and behaviors [1-3,5]. The array of symptoms and functioning in adults with ADHD suggests a multimodal treatment approach requiring a sophisticated treatment solution that can address the variety of symptoms. The need to find a viable solution that can alleviate the burden of the varied symptoms of adults with ADHD, including the symptoms coming from coexisting disorders, is further emphasized by the worldwide prevalence of ADHD in the general adult population, which is approximately 2.5%. In addition, it is associated with substantial individual impacts such as difficulties in interpersonal functioning, educational and occupational performance, and community activities [6-9]. Patients with ADHD also have a high risk of criminal behavior and substance use disorders, an increased risk of accidents or unintentional injuries [10-13], and poor health and lifestyle choices [14-16]. Moreover, as many as 80% of patients with ADHD have at least 1 coexisting psychiatric disorder [6,17,18]. The most frequent comorbid psychopathologies include mood and anxiety disorders, bipolar disorder, and personality disorders. Approximately 20% to 50% of adults with ADHD have major depressive disorder (MDD) or dysthymia, whereas approximately 1 in 2 struggles with anxiety disorders (generalized anxiety disorder [GAD]) [17]. The co-occurrence of these disorders adds to the complexity of finding utility in as well as adherence to a treatment option. This highlights the need to find therapeutic solutions for the population with ADHD who have comorbid depression and anxiety disorders that will alleviate symptoms and positively affect their quality of life. Traditionally, the treatment options for adults with ADHD are medication or psychotherapy as stand-alone treatments or in combination with each other. Although the standard of care for the comorbidity of MDD and GAD is similar to that of ADHD [17], the presence of these symptoms can mask symptoms of ADHD and forestall the diagnosis of ADHD in adults, which prevents the population from receiving appropriate treatment that addresses ADHD [3,5,17]. In addition, symptoms of depression and anxiety can create a barrier to the use of any relevant treatment option for ADHD [10,18,19]. An additional treatment factor to consider is that adults with ADHD tend to prefer nonpharmacological options for managing their symptoms [20,21]. Therefore, psychotherapy, which includes behavioral and cognitive behavioral therapy (CBT) both individually and in groups as well as skills training, can provide a suitable treatment option [22-24]. Finally, it is important to mention that the effectiveness of any intervention is closely related to keeping regular appointments and adherence to treatment recommendations [25,26]. Digital therapeutic solutions may present a promising alternative treatment option that could mitigate these challenges. The scientific community has made great efforts to improve adherence and engagement with the introduction of tools such as digital mental health interventions. These digital tools stem from mobile health or digital health research to support behavior change, which has grown in relevance over the past 2 decades [27]. Digital interventions have the potential to evoke changes unavailable in traditional methods because of the ability to design personalized treatment models and measure engagement [28-30]. Increasing evidence focusing on the effectiveness of these interventions for MDD and GAD exists in the literature [31,32]. In addition, there is early evidence for adults with ADHD that shows positive clinical outcomes, suggesting that a digital solution can help improve co-occurring symptoms and daily functioning by providing digitally designed programs to meet the patient’s needs [1,20,21,33,34]. Furthermore, as many patients with ADHD prefer a nonpharmacological option to manage their symptoms [20,35], digital mental health interventions may offer a viable solution to meet their treatment needs. Patient adherence may also be improved by providing evidence-based solutions such as 24/7 access to educational information and resources, personalized support, and targeted interventions and skills training via technology (eg, apps or websites) [21,35] in the comfort of their own homes [20,30]. Digital mental health interventions are novel solutions, and consideration should also be given to newly developed industry guidelines and socioeconomic and cultural determinants that affect design and engagement [36-38]. Therefore, it is important to test the feasibility of new data-driven digital mental health interventions for adults with ADHD and comorbidities with the aim of improving their overall mental health status and quality of life. In this study, we used a digital mental health solution that was designed and developed by Feel Therapeutics in the context of a real-world data, proof-of-concept study targeting a population with ADHD symptomatology and coexisting depressive or anxiety symptoms. The specific solution regards a digital, data-driven mental health support program that spans a 16-week period and combines emotion journaling, evidence-based CBT, mindfulness, and positive psychology techniques augmented with the Feel Digital Precision Medicine Platform. For this study, the main components of the program are (1) the Feel mobile app, which enables participants to journal their emotions, have access to other mental health–related metrics, and participate in the weekly sessions; (2) personalized weekly 15-minute coaching sessions; and (3) structured weekly mental health educational material and exercises. In addition, a wrist-worn device, the Feel Emotion Sensor, which continuously monitors changes in the participants’ autonomic nervous system and captures a series of mental health–related metrics, is provided as an optional component.
What the sources say
- Supportedcites [20] source
The Introduction section, “Internet-Delivered Interventions for Adults With ADHD,” explicitly states that many adults with ADHD prefer a nonpharmacological option for managing their symptoms. This supports the citing sentence’s paraphrase. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [21] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“symptoms of depression and anxiety can create a barrier to the use of any relevant treatment option for ADHD [10,18,19].”
§ A Digital Mental Health Support Program for Depression and Anxiety in Populations With Attention-Deficit/Hyperactivity Disorder: Feasibility and Usability Study > Introduction > Background Attention-deficit/hyperactivity disorder (ADHD), as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), is a heritable, chronic, and neurobehavioral disorder of childhood onset and is characterized by symptoms of inattentiveness and hyperactivity-impulsivity [1]. Although the exact etiology of ADHD is still unknown, there is an ever-growing body of neurobiological evidence that supports a multifaceted neurodiversity that contributes to impairment in multiple domains, such as cognitive processing, attention, motor planning, speed of processing responses, and other behavioral issues observed in ADHD [2]. Specifically, the prefrontal cortex, caudate, and cerebellum regions are interconnected by a network of neurons and together regulate attention, thoughts, emotions, behavior, and actions [1,3]. This neurobiological research adds a layer of insight into the presentation of ADHD symptoms, which begin in childhood, affecting the level of quality in social and occupational functioning, and continue to cause problems into adulthood for approximately 29% of people diagnosed [4]. The typical clinical picture of adults with ADHD is characterized by inattention or hyperfocus, hyperactivity, mind wandering, and impulsivity. Furthermore, emotional dysregulation and functional impairment are also characteristic features of adults with ADHD [1,2,5]. In terms of emotional dysregulation, the observed emotional changes are short-lived and usually triggered by daily activities [1-3,5], whereas functional deficits mainly include problems with inhibition and working memory; organizing, prioritizing, and initiating work; focusing, sustaining, and shifting attention to tasks; managing frustration; and self-regulating emotions and behaviors [1-3,5]. The array of symptoms and functioning in adults with ADHD suggests a multimodal treatment approach requiring a sophisticated treatment solution that can address the variety of symptoms. The need to find a viable solution that can alleviate the burden of the varied symptoms of adults with ADHD, including the symptoms coming from coexisting disorders, is further emphasized by the worldwide prevalence of ADHD in the general adult population, which is approximately 2.5%. In addition, it is associated with substantial individual impacts such as difficulties in interpersonal functioning, educational and occupational performance, and community activities [6-9]. Patients with ADHD also have a high risk of criminal behavior and substance use disorders, an increased risk of accidents or unintentional injuries [10-13], and poor health and lifestyle choices [14-16]. Moreover, as many as 80% of patients with ADHD have at least 1 coexisting psychiatric disorder [6,17,18]. The most frequent comorbid psychopathologies include mood and anxiety disorders, bipolar disorder, and personality disorders. Approximately 20% to 50% of adults with ADHD have major depressive disorder (MDD) or dysthymia, whereas approximately 1 in 2 struggles with anxiety disorders (generalized anxiety disorder [GAD]) [17]. The co-occurrence of these disorders adds to the complexity of finding utility in as well as adherence to a treatment option. This highlights the need to find therapeutic solutions for the population with ADHD who have comorbid depression and anxiety disorders that will alleviate symptoms and positively affect their quality of life. Traditionally, the treatment options for adults with ADHD are medication or psychotherapy as stand-alone treatments or in combination with each other. Although the standard of care for the comorbidity of MDD and GAD is similar to that of ADHD [17], the presence of these symptoms can mask symptoms of ADHD and forestall the diagnosis of ADHD in adults, which prevents the population from receiving appropriate treatment that addresses ADHD [3,5,17]. In addition, symptoms of depression and anxiety can create a barrier to the use of any relevant treatment option for ADHD [10,18,19]. An additional treatment factor to consider is that adults with ADHD tend to prefer nonpharmacological options for managing their symptoms [20,21]. Therefore, psychotherapy, which includes behavioral and cognitive behavioral therapy (CBT) both individually and in groups as well as skills training, can provide a suitable treatment option [22-24]. Finally, it is important to mention that the effectiveness of any intervention is closely related to keeping regular appointments and adherence to treatment recommendations [25,26]. Digital therapeutic solutions may present a promising alternative treatment option that could mitigate these challenges. The scientific community has made great efforts to improve adherence and engagement with the introduction of tools such as digital mental health interventions. These digital tools stem from mobile health or digital health research to support behavior change, which has grown in relevance over the past 2 decades [27]. Digital interventions have the potential to evoke changes unavailable in traditional methods because of the ability to design personalized treatment models and measure engagement [28-30]. Increasing evidence focusing on the effectiveness of these interventions for MDD and GAD exists in the literature [31,32]. In addition, there is early evidence for adults with ADHD that shows positive clinical outcomes, suggesting that a digital solution can help improve co-occurring symptoms and daily functioning by providing digitally designed programs to meet the patient’s needs [1,20,21,33,34]. Furthermore, as many patients with ADHD prefer a nonpharmacological option to manage their symptoms [20,35], digital mental health interventions may offer a viable solution to meet their treatment needs. Patient adherence may also be improved by providing evidence-based solutions such as 24/7 access to educational information and resources, personalized support, and targeted interventions and skills training via technology (eg, apps or websites) [21,35] in the comfort of their own homes [20,30]. Digital mental health interventions are novel solutions, and consideration should also be given to newly developed industry guidelines and socioeconomic and cultural determinants that affect design and engagement [36-38]. Therefore, it is important to test the feasibility of new data-driven digital mental health interventions for adults with ADHD and comorbidities with the aim of improving their overall mental health status and quality of life. In this study, we used a digital mental health solution that was designed and developed by Feel Therapeutics in the context of a real-world data, proof-of-concept study targeting a population with ADHD symptomatology and coexisting depressive or anxiety symptoms. The specific solution regards a digital, data-driven mental health support program that spans a 16-week period and combines emotion journaling, evidence-based CBT, mindfulness, and positive psychology techniques augmented with the Feel Digital Precision Medicine Platform. For this study, the main components of the program are (1) the Feel mobile app, which enables participants to journal their emotions, have access to other mental health–related metrics, and participate in the weekly sessions; (2) personalized weekly 15-minute coaching sessions; and (3) structured weekly mental health educational material and exercises. In addition, a wrist-worn device, the Feel Emotion Sensor, which continuously monitors changes in the participants’ autonomic nervous system and captures a series of mental health–related metrics, is provided as an optional component.
What the sources say
- Could not verifycites [10] sourceExperimental — accuracy not yet measured
The Methods (Disorders; page unavailable) say the study did not examine internalizing disorders characterized by anxiety. The Discussion mentions access to care and poor treatment adherence, but does not link either to depression or anxiety. Searches for depression, anxiety, and barriers to ADHD treatment found no passage addressing the claimed relationship. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [18] source
- Not checked — no full text of the sourcecites [19] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Patient adherence may also be improved by providing evidence-based solutions such as 24/7 access to educational information and resources, personalized support, and targeted interventions and skills training via technology (eg, apps or websites) [21,35] in the comfort of their own homes [20,30].”
§ A Digital Mental Health Support Program for Depression and Anxiety in Populations With Attention-Deficit/Hyperactivity Disorder: Feasibility and Usability Study > Introduction > Background Attention-deficit/hyperactivity disorder (ADHD), as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), is a heritable, chronic, and neurobehavioral disorder of childhood onset and is characterized by symptoms of inattentiveness and hyperactivity-impulsivity [1]. Although the exact etiology of ADHD is still unknown, there is an ever-growing body of neurobiological evidence that supports a multifaceted neurodiversity that contributes to impairment in multiple domains, such as cognitive processing, attention, motor planning, speed of processing responses, and other behavioral issues observed in ADHD [2]. Specifically, the prefrontal cortex, caudate, and cerebellum regions are interconnected by a network of neurons and together regulate attention, thoughts, emotions, behavior, and actions [1,3]. This neurobiological research adds a layer of insight into the presentation of ADHD symptoms, which begin in childhood, affecting the level of quality in social and occupational functioning, and continue to cause problems into adulthood for approximately 29% of people diagnosed [4]. The typical clinical picture of adults with ADHD is characterized by inattention or hyperfocus, hyperactivity, mind wandering, and impulsivity. Furthermore, emotional dysregulation and functional impairment are also characteristic features of adults with ADHD [1,2,5]. In terms of emotional dysregulation, the observed emotional changes are short-lived and usually triggered by daily activities [1-3,5], whereas functional deficits mainly include problems with inhibition and working memory; organizing, prioritizing, and initiating work; focusing, sustaining, and shifting attention to tasks; managing frustration; and self-regulating emotions and behaviors [1-3,5]. The array of symptoms and functioning in adults with ADHD suggests a multimodal treatment approach requiring a sophisticated treatment solution that can address the variety of symptoms. The need to find a viable solution that can alleviate the burden of the varied symptoms of adults with ADHD, including the symptoms coming from coexisting disorders, is further emphasized by the worldwide prevalence of ADHD in the general adult population, which is approximately 2.5%. In addition, it is associated with substantial individual impacts such as difficulties in interpersonal functioning, educational and occupational performance, and community activities [6-9]. Patients with ADHD also have a high risk of criminal behavior and substance use disorders, an increased risk of accidents or unintentional injuries [10-13], and poor health and lifestyle choices [14-16]. Moreover, as many as 80% of patients with ADHD have at least 1 coexisting psychiatric disorder [6,17,18]. The most frequent comorbid psychopathologies include mood and anxiety disorders, bipolar disorder, and personality disorders. Approximately 20% to 50% of adults with ADHD have major depressive disorder (MDD) or dysthymia, whereas approximately 1 in 2 struggles with anxiety disorders (generalized anxiety disorder [GAD]) [17]. The co-occurrence of these disorders adds to the complexity of finding utility in as well as adherence to a treatment option. This highlights the need to find therapeutic solutions for the population with ADHD who have comorbid depression and anxiety disorders that will alleviate symptoms and positively affect their quality of life. Traditionally, the treatment options for adults with ADHD are medication or psychotherapy as stand-alone treatments or in combination with each other. Although the standard of care for the comorbidity of MDD and GAD is similar to that of ADHD [17], the presence of these symptoms can mask symptoms of ADHD and forestall the diagnosis of ADHD in adults, which prevents the population from receiving appropriate treatment that addresses ADHD [3,5,17]. In addition, symptoms of depression and anxiety can create a barrier to the use of any relevant treatment option for ADHD [10,18,19]. An additional treatment factor to consider is that adults with ADHD tend to prefer nonpharmacological options for managing their symptoms [20,21]. Therefore, psychotherapy, which includes behavioral and cognitive behavioral therapy (CBT) both individually and in groups as well as skills training, can provide a suitable treatment option [22-24]. Finally, it is important to mention that the effectiveness of any intervention is closely related to keeping regular appointments and adherence to treatment recommendations [25,26]. Digital therapeutic solutions may present a promising alternative treatment option that could mitigate these challenges. The scientific community has made great efforts to improve adherence and engagement with the introduction of tools such as digital mental health interventions. These digital tools stem from mobile health or digital health research to support behavior change, which has grown in relevance over the past 2 decades [27]. Digital interventions have the potential to evoke changes unavailable in traditional methods because of the ability to design personalized treatment models and measure engagement [28-30]. Increasing evidence focusing on the effectiveness of these interventions for MDD and GAD exists in the literature [31,32]. In addition, there is early evidence for adults with ADHD that shows positive clinical outcomes, suggesting that a digital solution can help improve co-occurring symptoms and daily functioning by providing digitally designed programs to meet the patient’s needs [1,20,21,33,34]. Furthermore, as many patients with ADHD prefer a nonpharmacological option to manage their symptoms [20,35], digital mental health interventions may offer a viable solution to meet their treatment needs. Patient adherence may also be improved by providing evidence-based solutions such as 24/7 access to educational information and resources, personalized support, and targeted interventions and skills training via technology (eg, apps or websites) [21,35] in the comfort of their own homes [20,30]. Digital mental health interventions are novel solutions, and consideration should also be given to newly developed industry guidelines and socioeconomic and cultural determinants that affect design and engagement [36-38]. Therefore, it is important to test the feasibility of new data-driven digital mental health interventions for adults with ADHD and comorbidities with the aim of improving their overall mental health status and quality of life. In this study, we used a digital mental health solution that was designed and developed by Feel Therapeutics in the context of a real-world data, proof-of-concept study targeting a population with ADHD symptomatology and coexisting depressive or anxiety symptoms. The specific solution regards a digital, data-driven mental health support program that spans a 16-week period and combines emotion journaling, evidence-based CBT, mindfulness, and positive psychology techniques augmented with the Feel Digital Precision Medicine Platform. For this study, the main components of the program are (1) the Feel mobile app, which enables participants to journal their emotions, have access to other mental health–related metrics, and participate in the weekly sessions; (2) personalized weekly 15-minute coaching sessions; and (3) structured weekly mental health educational material and exercises. In addition, a wrist-worn device, the Feel Emotion Sensor, which continuously monitors changes in the participants’ autonomic nervous system and captures a series of mental health–related metrics, is provided as an optional component.
What the sources say
- Not checked — no full text of the sourcecites [21] source
- Partly supportedcites [35] sourceExperimental — accuracy not yet measured
The Method section describes an app offering CBT psychoeducation, daily skills exercises, personal goals, reminders, and peer support; the Discussion says apps may be a feasible way to deliver these resources in daily life. The paper does not establish that these features improve patient adherence or explicitly document 24/7 access. Its findings concern the usability and feasibility of an app for adults with ADHD, not adherence across patients generally. (LLM, conf=0.84)
- Partly supportedcites [20] sourceExperimental — accuracy not yet measured
The Introduction section on internet-delivered interventions for adults with ADHD describes technology providing information, tailored advice, support, skills training, and 24/7 access. It does not say those features themselves improve adherence; the following paragraph instead links potential adherence improvements to user-centered design and good usability. (LLM, conf=0.84)
- Partly supportedcites [30] sourceExperimental — accuracy not yet measured
The “Improving app engagement” section says health education and clinician or peer support may increase engagement, and that embedding apps in users’ settings can enhance adherence (page not provided). It does not establish that 24/7 access, personalized support, or targeted skills training as a package improves patient adherence. (LLM, conf=0.84)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“psychotherapy, which includes behavioral and cognitive behavioral therapy (CBT) both individually and in groups as well as skills training, can provide a suitable treatment option [22-24].”
§ A Digital Mental Health Support Program for Depression and Anxiety in Populations With Attention-Deficit/Hyperactivity Disorder: Feasibility and Usability Study > Introduction > Background Attention-deficit/hyperactivity disorder (ADHD), as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), is a heritable, chronic, and neurobehavioral disorder of childhood onset and is characterized by symptoms of inattentiveness and hyperactivity-impulsivity [1]. Although the exact etiology of ADHD is still unknown, there is an ever-growing body of neurobiological evidence that supports a multifaceted neurodiversity that contributes to impairment in multiple domains, such as cognitive processing, attention, motor planning, speed of processing responses, and other behavioral issues observed in ADHD [2]. Specifically, the prefrontal cortex, caudate, and cerebellum regions are interconnected by a network of neurons and together regulate attention, thoughts, emotions, behavior, and actions [1,3]. This neurobiological research adds a layer of insight into the presentation of ADHD symptoms, which begin in childhood, affecting the level of quality in social and occupational functioning, and continue to cause problems into adulthood for approximately 29% of people diagnosed [4]. The typical clinical picture of adults with ADHD is characterized by inattention or hyperfocus, hyperactivity, mind wandering, and impulsivity. Furthermore, emotional dysregulation and functional impairment are also characteristic features of adults with ADHD [1,2,5]. In terms of emotional dysregulation, the observed emotional changes are short-lived and usually triggered by daily activities [1-3,5], whereas functional deficits mainly include problems with inhibition and working memory; organizing, prioritizing, and initiating work; focusing, sustaining, and shifting attention to tasks; managing frustration; and self-regulating emotions and behaviors [1-3,5]. The array of symptoms and functioning in adults with ADHD suggests a multimodal treatment approach requiring a sophisticated treatment solution that can address the variety of symptoms. The need to find a viable solution that can alleviate the burden of the varied symptoms of adults with ADHD, including the symptoms coming from coexisting disorders, is further emphasized by the worldwide prevalence of ADHD in the general adult population, which is approximately 2.5%. In addition, it is associated with substantial individual impacts such as difficulties in interpersonal functioning, educational and occupational performance, and community activities [6-9]. Patients with ADHD also have a high risk of criminal behavior and substance use disorders, an increased risk of accidents or unintentional injuries [10-13], and poor health and lifestyle choices [14-16]. Moreover, as many as 80% of patients with ADHD have at least 1 coexisting psychiatric disorder [6,17,18]. The most frequent comorbid psychopathologies include mood and anxiety disorders, bipolar disorder, and personality disorders. Approximately 20% to 50% of adults with ADHD have major depressive disorder (MDD) or dysthymia, whereas approximately 1 in 2 struggles with anxiety disorders (generalized anxiety disorder [GAD]) [17]. The co-occurrence of these disorders adds to the complexity of finding utility in as well as adherence to a treatment option. This highlights the need to find therapeutic solutions for the population with ADHD who have comorbid depression and anxiety disorders that will alleviate symptoms and positively affect their quality of life. Traditionally, the treatment options for adults with ADHD are medication or psychotherapy as stand-alone treatments or in combination with each other. Although the standard of care for the comorbidity of MDD and GAD is similar to that of ADHD [17], the presence of these symptoms can mask symptoms of ADHD and forestall the diagnosis of ADHD in adults, which prevents the population from receiving appropriate treatment that addresses ADHD [3,5,17]. In addition, symptoms of depression and anxiety can create a barrier to the use of any relevant treatment option for ADHD [10,18,19]. An additional treatment factor to consider is that adults with ADHD tend to prefer nonpharmacological options for managing their symptoms [20,21]. Therefore, psychotherapy, which includes behavioral and cognitive behavioral therapy (CBT) both individually and in groups as well as skills training, can provide a suitable treatment option [22-24]. Finally, it is important to mention that the effectiveness of any intervention is closely related to keeping regular appointments and adherence to treatment recommendations [25,26]. Digital therapeutic solutions may present a promising alternative treatment option that could mitigate these challenges. The scientific community has made great efforts to improve adherence and engagement with the introduction of tools such as digital mental health interventions. These digital tools stem from mobile health or digital health research to support behavior change, which has grown in relevance over the past 2 decades [27]. Digital interventions have the potential to evoke changes unavailable in traditional methods because of the ability to design personalized treatment models and measure engagement [28-30]. Increasing evidence focusing on the effectiveness of these interventions for MDD and GAD exists in the literature [31,32]. In addition, there is early evidence for adults with ADHD that shows positive clinical outcomes, suggesting that a digital solution can help improve co-occurring symptoms and daily functioning by providing digitally designed programs to meet the patient’s needs [1,20,21,33,34]. Furthermore, as many patients with ADHD prefer a nonpharmacological option to manage their symptoms [20,35], digital mental health interventions may offer a viable solution to meet their treatment needs. Patient adherence may also be improved by providing evidence-based solutions such as 24/7 access to educational information and resources, personalized support, and targeted interventions and skills training via technology (eg, apps or websites) [21,35] in the comfort of their own homes [20,30]. Digital mental health interventions are novel solutions, and consideration should also be given to newly developed industry guidelines and socioeconomic and cultural determinants that affect design and engagement [36-38]. Therefore, it is important to test the feasibility of new data-driven digital mental health interventions for adults with ADHD and comorbidities with the aim of improving their overall mental health status and quality of life. In this study, we used a digital mental health solution that was designed and developed by Feel Therapeutics in the context of a real-world data, proof-of-concept study targeting a population with ADHD symptomatology and coexisting depressive or anxiety symptoms. The specific solution regards a digital, data-driven mental health support program that spans a 16-week period and combines emotion journaling, evidence-based CBT, mindfulness, and positive psychology techniques augmented with the Feel Digital Precision Medicine Platform. For this study, the main components of the program are (1) the Feel mobile app, which enables participants to journal their emotions, have access to other mental health–related metrics, and participate in the weekly sessions; (2) personalized weekly 15-minute coaching sessions; and (3) structured weekly mental health educational material and exercises. In addition, a wrist-worn device, the Feel Emotion Sensor, which continuously monitors changes in the participants’ autonomic nervous system and captures a series of mental health–related metrics, is provided as an optional component.
What the sources say
- Not checked — no full text of the sourcecites [22] source
- Not checked — no full text of the sourcecites [23] source
- Supportedcites [24] source
The Description of the intervention section describes CBT for adults with ADHD delivered individually or in groups and incorporating behavioural strategies and skills training. The Authors’ Conclusions say cognitive-behavioural treatments may be efficacious in the short term, supporting the qualified claim that psychotherapy can be a suitable option. (LLM, conf=0.91)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These core interventions have been scientifically validated to support positive clinical outcomes [47].”
§ A Digital Mental Health Support Program for Depression and Anxiety in Populations With Attention-Deficit/Hyperactivity Disorder: Feasibility and Usability Study > Methods > Intervention: The Feel Program for Populations With ADHD
What the sources say
- Partly supportedcites [47] sourceExperimental — accuracy not yet measured
The Abstract reports a randomized controlled trial in which CBT for medication-treated adults with ADHD significantly reduced ADHD, anxiety, and depressive symptoms compared with continued medication alone. The paper does not provide evidence that mindfulness or positive psychology interventions produce positive clinical outcomes, so it supports only the CBT part of the claim. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
55 more claims · 2 with their cited sources checked
Create a free account to see all 112 claims and every source verdict.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 27
- Borderline: one of the tests for a substantial claim is unclear. 1
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
The satisfaction with life scale
Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4901_13 · Cited by 31,768 · cited 1×
“The SWLS is a 5-item self-administered subjective well-being questionnaire that measures global life satisfaction [43].”
BackgroundA Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765 · cited 1×
“The GAD-7 is a 7-item self-administered questionnaire that serves as a brief clinical measure for assessing the severity of GAD [40].”
MethodStages and processes of self-change of smoking: Toward an integrative model of change.
Prochaska, J. O., & DiClemente, C. C. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.51.3.390 · Cited by 9,098 · cited 1×
“In addition, the behavioral coping strategies and interventions are aligned with the transtheoretical model, also referred to as the stages of change model (ie, contemplation, preparation, action, maintenance, and relapse) [44,45], along with motivational interviewing in the weekly sessions.”
MethodSekhon, M., Cartwright, M., & Francis, J. J. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2031-8 · Cited by 3,938 · cited 1×
“The acceptability of the program was assessed based on 3 different time points in relation to the intervention delivery period [58].”
MethodMachine learning for neuroimaging with scikit-learn
Abraham, A., Pedregosa, F., Eickenberg, M., Gervais, P., Mueller, A., Kossaifi, J., Gramfort, A., Thirion, B., & Varoquaux, G. (2014) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2014.00014 · Cited by 2,384 · cited 1×
“We imputed the missing values using the multivariate feature imputation available in the open-source scikit-learn Python package (Python Software Foundation) [53].”
MethodThe Transtheoretical Approach: Crossing Traditional Boundaries of Therapy
Sporakowski, M. J., Prochaska, J. O., & DiClemente, C. C. (1986) · Family Relations · doi:10.2307/584540 · Cited by 1,975 · cited 1×
“In addition, the behavioral coping strategies and interventions are aligned with the transtheoretical model, also referred to as the stages of change model (ie, contemplation, preparation, action, maintenance, and relapse) [44,45], along with motivational interviewing in the weekly sessions.”
MethodInternational Encyclopedia of Statistical Science
(2011) · Springer eBooks · doi:10.1007/978-3-642-04898-2 · Cited by 1,653
T test as a parametric statistic
Kim, T. K. (2015) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2015.68.6.540 · Cited by 1,436 · cited 1×
“Consequently, as an alternative to the paired t test, which requires that the paired differences be normally distributed [48], we used the 2-tailed Wilcoxon signed rank test to investigate the statistical significance of our results.”
MethodAndrews, G., Basu, A., Cuijpers, P., Craske, M. G., McEvoy, P., English, C. L., & Newby, J. M. (2018) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2018.01.001 · Cited by 922 · cited 1×
“Increasing evidence focusing on the effectiveness of these interventions for MDD and GAD exists in the literature [31,32].”
Background
Research works printed but not linked: 2
- 2013, The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
- Barkley, RA, 2011, Barkley Adult ADHD Rating Scale--IV
Cited by
Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment
Fu, X., Wu, W., Wu, Y., Liu, X., Liang, W., Wu, R., & Li, Y. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1597559 · Cited by 54
Fatouros, P., Tsirmpas, C., Andrikopoulos, D., Kaplow, S., Kontoangelos, K. A., & Papageorgiou, C. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01511-7 · Cited by 33
Self-citationPatrickson, B., Shams, L., Fouyaxis, J., Strobel, J. E., Schubert, K. O., Musker, M., & Bidargaddi, N. P. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21050582 · Cited by 9
“…offering effective alternative delivery pathways for psychoeducational therapy, including self-guided ADHD psychoeducation based on a chatbot or conventional app [40], or else in combination with physiological health data monitoring (via a wrist-worn sensor) and tele-health coaching sessions [41].”
BackgroundTransformer-Based Decomposition of Electrodermal Activity for Real-World Mental Health Applications
Tsirmpas, C., Konstantopoulos, S., Andrikopoulos, D., Kyriakouli, K., & Fatouros, P. (2025) · Sensors · doi:10.3390/s25144406 · Cited by 12
“Our dataset is extracted from data acquired in previous studies by Tsirmpas et al. [43, 44], comprising longitudinal EDA data collected over a 16-week period from 40 individuals.”
Self-citationJeannic, A. L., Michel, M., Hayek, C. E., & Chevreul, K. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.110 · Cited by 3
Takae, A., Sasaki, N., Imamura, K., & Nishi, D. (2025) · JMIR mhealth and uhealth · doi:10.2196/73512 · Cited by 3
Digital health technologies for adults with ADHD: a scoping review
Schofield, F. J., Wilkie, S., Nielsen, E. E., Brigden, A., Jones, M. W., & Isotalus, H. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2026.1746732 · Cited by 4
Instructional Emphasis and PHQ-9 and GAD-7 Scores Among Participants With Anxiety or Depression
Young, S. D., Cumberland, W. G., Fehmie, D. A., & Ugarte, D. A. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.23952 · Cited by 2
SafePlace: A Mobile Application Prototype for Supporting People with Anxiety
Moyano, M., Narváez, J. C., Olmedo, A., Guerrero, G., & Chiliquinga, C. (2025) · Communications in computer and information science · doi:10.1007/978-3-031-83207-9_21
Ghozali, M. T. (2025) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2025.00824
Baou, C. E., Suh, J. W., Saunders, R., Buckman, J. E. J., Hickmott, N., Corrigan, L., Clements, H., Dagnan, D., Donnellan, W. J., Mandy, W., et al. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101798
“8 Consequently, to our knowledge there are currently no studies evaluating whether evidence-based psychological therapies offered in non-ADHD-specialist services are also effective for people with ADHD.”
Metadata
- Authors
- Tsirmpas, C., Nikolakopoulou, M., Kaplow, S., Andrikopoulos, D., Fatouros, P., Kontoangelos, K., & Papageorgiou, C.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- University Mental Health Research Institute (GR)
- Corresponding author
- Andrikopoulos, Dimitrios
- ORCID
- Venue
- JMIR Formative Research
- Publisher
- JMIR Publications Inc.
- Published
- 2023-10-11
- Volume
- 7
- Pages
- e48362
- ISSN
- 2561-326X (ISSN-L)
- PMC
- PMC10600652
- OpenAlex
- W4387539919
- Cited by
- 11
- References
- 63
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 1
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR Formative Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- digital mental health interventions, attention deficit hyperactivity disorder, depression, anxiety, psychiatric comorbidity, cognitive behavioral therapy, mindfulness, positive psychology, personalized interventions, feasibility and usability, quality of life, life satisfaction, emotion monitoring, mobile health apps, adult ADHD, medication adherence, user experience, real-world data, PHQ-9, GAD-7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.